1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Vicarious Surgical Inc

D8 Holdings Corp. is a recently formed company whose business purpose is merger and acquisitions in the consumer sector. The company's objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement.


Vicarious Surgical Receives Continued Listing Standard Notice From NYSE | RBOT Stock News
Sep 22, 2023 22:00pm

Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve patient outcomes as well as both the

Source:Stock Titan
Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24, 2023 21:42pm

Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. Read why RBOT stock is a hold.

Source:Seeking Alpha
$8M Bet On Vicarious Surgical? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Aug 10, 2023 12:33pm

The Dow Jones closed lower by around 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Container Store Group The Trade: The Container Store Group, Inc. (NYSE: TCS ) Chief Operating Officer Dhritiman Saha acquired a total of 5,000 shares an average price of $2.54. To acquire these shares, … Full story available on Benzinga.com

Why Vicarious Surgical Shares Are Getting Hammered
Aug 07, 2023 14:45pm

Vicarious Surgical Inc (NYSE: RBOT ) shares are trading lower by 8.5% to $0.87 Monday morning on downward momentum after the company last week priced a $45 million offering. What Else? Vicarious Surgical priced its underwritten public offering of 45 million shares of … Full story available on Benzinga.com